BioTech | 31 May 2023 | Opinion
“We'll focus on genomic medicine and growing our business in China”
What is the strategic rationale for the merger, and how does it fit into the long-term growth plans of both co...Read more
Pharma | 31 May 2023 | Opinion
What are some of your key areas of focus in R&D and what’s your approach toward pharma innovation?&n...Read more
World | 02 May 2023 | Opinion
Importance of HPV Testing and Genotyping in Cervical Cancer Prevention
Dr. Mohd Azizuddin bin Mohd Yussof, CT (IAC), Bsc. (Biomedical), MHealthSc. (Biomedical), PhD (Pathology) is t...Read more
Medical Diagnostic | 31 May 2023 | Opinion
“We plan to manufacture one million tests of VANSCAN Typhoid RT PCR test in our first year in India”
Please share some details about the global Typhoid Diagnostics market. Where does India stand in terms of dise...Read more
Korea | 08 June 2023 | News
US-based Rani Therapeutics expands biologics partnership with Korean firm Celltrion
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused on the oral delivery of biologics...Read more
World | 07 June 2023 | News
China's Fosun Pharma partners with IFC to improve access to high quality medicines in Africa
To support stronger healthcare delivery and outcomes in West Africa, Shanghai Fosun Pharmaceutical (...Read more
Pharma | 07 June 2023 | News
CPHI events report strong performance in Asia
The CPHI series of pharma events, the largest exhibitions in pharma, have seen significant growth in Asia in t...Read more
Japan | 08 June 2023 | News
Japanese firm Shimadzu invests in ChromaCode for developing scalable PCR technology
Japan-based Shimadzu Corporation has invested in ChromaCode Inc., a US-based startup with technology to expand...Read more
Malaysia | 08 June 2023 | News
China's BGI Genomics receives approval for colorectal cancer detection kit in Malaysia
China-based BGI Genomics' COLOTECT 1.0 DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C ...Read more
North America | 05 June 2023 | News
Fujifilm Cellular Dynamics, a leading global developer and manufacturer of human induced pluripotent stem ...Read more
Singapore | 02 June 2023 | News
Singapore uses AI to accelerate discovery of biomarkers for chronic myeloid leukaemia treatment
Scientists at Duke-NUS Medical School, A*STAR’s Genome Institute of Singapore (GIS), Singapore General H...Read more
Malaysia | 08 June 2023 | News
China's BGI Genomics receives approval for colorectal cancer detection kit in Malaysia
China-based BGI Genomics' COLOTECT 1.0 DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C ...Read more
China | 06 June 2023 | News
Scivita Medical opens Headquarters, R&D and manufacturing plant in Suzhou Industrial Park
China-based startup Scivita Medical's headquarters, R&D and manufacturing plant has been officially opened...Read more
Japan | 06 June 2023 | News
Medtech firm Olympus to establish digital excellence centres in Hamburg, Boston and Tokyo
Japan-headquartered Olympus, a global medtech company, has announced the plan to establish a series of D...Read more
Europe | 02 June 2023 | News
WuXi Biologics to increase manufacturing capacity in Germany
China-headquartered WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organis...Read more
Singapore | 24 May 2023 | News
West Pharmaceutical Services inaugurates advanced manufacturing facility in Singapore
West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug adminis...Read more
China | 19 May 2023 | News
GenScript expands peptide and oligonucleotide production facility in China
US-based GenScript Biotech Corporation has expanded its primary manufacturing facility for oligonucleotide and...Read more
Korea | 04 May 2023 | News
Merck to open new Asia-Pacific Bioprocessing Centre in South Korea
US-based science and technology company, Merck has signed a non-binding Memorandum of Understanding (MoU) with...Read more
TAPPING FULL POTENTIAL OF NANOPARTICLES
Nanoparticles are another powerful tool in the biotech industry’s arsenal for targeted drug delivery. Their extremely small size, measured in nanometres, makes them highly effective carriers for therapeutic agents. These miniature carriers can be customised to encase drugs, benefiting from their biocompatibility, controlled release capabilities, stability, and low toxicity. The precision offered by nanoparticles opens up a world of possibilities for treating various diseases, including infectious diseases, cancer, and neurological disorders. These tiny particles offer tremendous potential for targeted drug delivery, enhanced therapeutic efficacy and precise disease targeting. Moreover, the global market for nanoparticle drug delivery is projected to grow significantly, reaching $123.6 billion by 2025, according to BCC Research. Let’s deep dive into the fascinating field of nanomedicines, advancements and challenges in nanoparticle drug delivery.
For Feedback Email Us: communications@biospectrumasia.com
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
+65 90150305
